General Information of Drug (ID: DM1NOEK)

Drug Name
Metreleptin Drug Info
Indication
Disease Entry ICD 11 Status REF
Acquired generalized lipodystrophy Approved [1]
Congenital generalized lipodystrophy Approved [1]
Diabetic complication 5A2Y Approved [2]
Acquired partial lipodystrophy Investigative [1]
Cross-matching ID
TTD Drug ID
DM1NOEK

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Investigative Drug(s)
Drug(s) Targeting Leptin receptor (LEPR)
Drug Name Drug ID Indication ICD 11 Highest Status REF
AMPE4L DM64X25 Diabetic complication 5A2Y Investigative [4]
PEGylated leptin DMZ01PS Obesity 5B81 Investigative [4]
BL-5040 DMGULNZ Cachexia MG20 Investigative [4]
ANG-2004 DMK1IMC Obesity 5B81 Investigative [4]
AMPSL DMXRIUT Diabetic complication 5A2Y Investigative [4]
Leptin DM5LY1H Alzheimer disease 8A20 Investigative [4]
EDP-21 DMMN0GO Obesity 5B81 Investigative [4]
AMPPL DMVHOQE Diabetic complication 5A2Y Investigative [4]
PEG-LPA-2 DMY293M Solid tumour/cancer 2A00-2F9Z Investigative [4]
⏷ Show the Full List of 9 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Leptin receptor (LEPR) TT0HD6V LEPR_HUMAN Modulator [3]

References

1 Lipodystrophy Syndromes. Endocrinol Metab Clin North Am. 2016 Dec;45(4):783-797.
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7333).
3 2014 FDA drug approvals. Nat Rev Drug Discov. 2015 Feb;14(2):77-81.
4 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1712).